Tsugumine Shu
Direttore/Membro del Consiglio presso I'ROM GROUP CO., LTD.
Patrimonio netto: 510 685 $ in data 30/04/2024
Relazioni attive
Nome | Sesso | Età | Società collegate | Collaborazione |
---|---|---|---|---|
Hiroaki Inukai | M | 58 | 14 anni | |
Toyotaka Mori | M | 65 |
Id Pharma Co., Ltd.
Id Pharma Co., Ltd. BiotechnologyHealth Technology Id Pharma Co., Ltd. manufactures and sells vaccine and gene therapy. The company utilizes its own vector platforms such as sendai virus vector in its business development, resulting in merits that are not readily available to other bio-companies. It is a workshop where scientists and engineers work together to realize their dreams of improving people's health and conquering incurable diseases by exploiting front-edge bioscience and technologies to their full potential. The firm is also a stage or base where the valuable efforts of its collaborators and supporters will come to big fruition. It believes that the promotion of creative collaborations with worldwide partners using its unique gene transfer technologies are the driving force of rapid and sure creation of valuable products and services. The company was founded on September 5, 2003 by Mamoru Hasegawa and is headquartered in Tsukuba, Japan. | 12 anni |
Kiyoshi Watanabe | M | 66 | 19 anni | |
Masaaki Matsushima | M | 59 | 26 anni | |
Shuichi Kojima | M | 55 | 19 anni | |
Toshiya Hara | M | 54 | 27 anni | |
Takeshi Takahashi | M | 53 | 6 anni | |
Toyoji Maeda | M | 63 | 3 anni | |
Atsushi Tsubaki | M | 64 | 5 anni | |
Hidetsugu Kuwahara | M | 55 | 27 anni | |
Minoriko Komaki | F | 67 | 6 anni | |
Hidetsugu Sasaki | M | 73 | 14 anni | |
Hiroyuki Fukase | M | 63 | 7 anni | |
Chikaaki Kato | M | 64 | 11 anni | |
Makoto Inoue | M | - |
Id Pharma Co., Ltd.
Id Pharma Co., Ltd. BiotechnologyHealth Technology Id Pharma Co., Ltd. manufactures and sells vaccine and gene therapy. The company utilizes its own vector platforms such as sendai virus vector in its business development, resulting in merits that are not readily available to other bio-companies. It is a workshop where scientists and engineers work together to realize their dreams of improving people's health and conquering incurable diseases by exploiting front-edge bioscience and technologies to their full potential. The firm is also a stage or base where the valuable efforts of its collaborators and supporters will come to big fruition. It believes that the promotion of creative collaborations with worldwide partners using its unique gene transfer technologies are the driving force of rapid and sure creation of valuable products and services. The company was founded on September 5, 2003 by Mamoru Hasegawa and is headquartered in Tsukuba, Japan. | 20 anni |
Naomi Ninagawa | F | - | 27 anni | |
Kiyomi Kindaichi | F | 61 |
Id Pharma Co., Ltd.
Id Pharma Co., Ltd. BiotechnologyHealth Technology Id Pharma Co., Ltd. manufactures and sells vaccine and gene therapy. The company utilizes its own vector platforms such as sendai virus vector in its business development, resulting in merits that are not readily available to other bio-companies. It is a workshop where scientists and engineers work together to realize their dreams of improving people's health and conquering incurable diseases by exploiting front-edge bioscience and technologies to their full potential. The firm is also a stage or base where the valuable efforts of its collaborators and supporters will come to big fruition. It believes that the promotion of creative collaborations with worldwide partners using its unique gene transfer technologies are the driving force of rapid and sure creation of valuable products and services. The company was founded on September 5, 2003 by Mamoru Hasegawa and is headquartered in Tsukuba, Japan. | 15 anni |
Kunikatsu Shirahata | M | - |
Id Pharma Co., Ltd.
Id Pharma Co., Ltd. BiotechnologyHealth Technology Id Pharma Co., Ltd. manufactures and sells vaccine and gene therapy. The company utilizes its own vector platforms such as sendai virus vector in its business development, resulting in merits that are not readily available to other bio-companies. It is a workshop where scientists and engineers work together to realize their dreams of improving people's health and conquering incurable diseases by exploiting front-edge bioscience and technologies to their full potential. The firm is also a stage or base where the valuable efforts of its collaborators and supporters will come to big fruition. It believes that the promotion of creative collaborations with worldwide partners using its unique gene transfer technologies are the driving force of rapid and sure creation of valuable products and services. The company was founded on September 5, 2003 by Mamoru Hasegawa and is headquartered in Tsukuba, Japan. | 20 anni |
Grafico relazionale
Relazione in diverse aziende
Relazioni precedenti
Nome | Sesso | Età | Società collegate | Collaborazione |
---|---|---|---|---|
Masaharu Inoue | M | 62 |
Id Pharma Co., Ltd.
Id Pharma Co., Ltd. BiotechnologyHealth Technology Id Pharma Co., Ltd. manufactures and sells vaccine and gene therapy. The company utilizes its own vector platforms such as sendai virus vector in its business development, resulting in merits that are not readily available to other bio-companies. It is a workshop where scientists and engineers work together to realize their dreams of improving people's health and conquering incurable diseases by exploiting front-edge bioscience and technologies to their full potential. The firm is also a stage or base where the valuable efforts of its collaborators and supporters will come to big fruition. It believes that the promotion of creative collaborations with worldwide partners using its unique gene transfer technologies are the driving force of rapid and sure creation of valuable products and services. The company was founded on September 5, 2003 by Mamoru Hasegawa and is headquartered in Tsukuba, Japan. | - |
Yohei Tanida | M | 62 |
Id Pharma Co., Ltd.
Id Pharma Co., Ltd. BiotechnologyHealth Technology Id Pharma Co., Ltd. manufactures and sells vaccine and gene therapy. The company utilizes its own vector platforms such as sendai virus vector in its business development, resulting in merits that are not readily available to other bio-companies. It is a workshop where scientists and engineers work together to realize their dreams of improving people's health and conquering incurable diseases by exploiting front-edge bioscience and technologies to their full potential. The firm is also a stage or base where the valuable efforts of its collaborators and supporters will come to big fruition. It believes that the promotion of creative collaborations with worldwide partners using its unique gene transfer technologies are the driving force of rapid and sure creation of valuable products and services. The company was founded on September 5, 2003 by Mamoru Hasegawa and is headquartered in Tsukuba, Japan. | - |
Masayoshi Kikuoka | M | 63 | - | |
Shiro Toba | M | 57 |
Id Pharma Co., Ltd.
Id Pharma Co., Ltd. BiotechnologyHealth Technology Id Pharma Co., Ltd. manufactures and sells vaccine and gene therapy. The company utilizes its own vector platforms such as sendai virus vector in its business development, resulting in merits that are not readily available to other bio-companies. It is a workshop where scientists and engineers work together to realize their dreams of improving people's health and conquering incurable diseases by exploiting front-edge bioscience and technologies to their full potential. The firm is also a stage or base where the valuable efforts of its collaborators and supporters will come to big fruition. It believes that the promotion of creative collaborations with worldwide partners using its unique gene transfer technologies are the driving force of rapid and sure creation of valuable products and services. The company was founded on September 5, 2003 by Mamoru Hasegawa and is headquartered in Tsukuba, Japan. | - |
Keiji Hasumi | M | 66 |
Tokyo University of Agriculture & Technology
| 3 anni |
Hayato Narisoko | M | 60 |
Tokyo University of Agriculture & Technology
| 4 anni |
Shitotomo Yamauchi | M | 91 | - | |
Tsumoru Miyano | M | 58 |
Tokyo University of Agriculture & Technology
| 4 anni |
Statistiche
Paese | Relazioni | % del totale |
---|---|---|
Giappone | 26 | 100.00% |
Età delle relazioni
Attive
Scorse
Uomo
Donna
Amministratori
Dirigenti
Provenienza delle relazioni
- Borsa valori
- Insiders
- Tsugumine Shu
- Contatti personali